We had identified two NSCLC cell lines with methylation of the Wnt7a promoter region, H157 and H1299, and wanted to determine the effect of treatment with a demethylating agent, 5-aza-2′ deoxycytidine (5 Aza). This evidence concerns the gene WNT7A and non-small cell lung carcinoma.